本页面由Tiger Trade Technology Pte. Ltd.提供服务

Protagonist Therapeutics Inc

103.59
+3.203.19%
成交量:30.85万
成交额:3,113.70万
市值:66.10亿
市盈率:-50.53
高:103.65
开:99.42
低:97.16
收:100.39
52周最高:105.69
52周最低:39.60
股本:6,380.87万
流通股本:4,315.48万
量比:0.60
换手率:0.71%
股息:- -
股息率:- -
每股收益(TTM):-2.0500
每股收益(LYR):-2.0500
净资产收益率:-20.18%
总资产收益率:-13.99%
市净率:10.75
市盈率(LYR):-50.53

数据加载中...

2026/03/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/25

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/25

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/25

重要事件披露

Form 8-K - Current report
2026/02/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/12

重要事件披露

Form 8-K - Current report
2025/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/06

重要事件披露

Form 8-K - Current report
2025/10/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities